Summary
Thirty-three patients with advanced transitional cell carcinoma of the urinary tract (23 bladder cases, 8 ureter cases, and 2 renal pelvis cases) were treated by three-drug combination chemotherapy using two protocols (protocol I: Adriamycin 50 mg/m2, cyclophosphamide 500 mg/m2, and 5-fluorouracil 500 mg/m2, protocol II: Adriamycin 50 mg/m2, cyclophosphamide 500 mg/m2, and cis-platinum 50 mg/m2). Protocol I induced responses in three of 19 patients (16%), (1 complete response, 2 partial responses), and protocol II (1 complete response, 4 partial responses) in five of 14 patients (36%). The overall response rate was 24%. The duration of response was relatively short (median duration 5.1 months). The combination therapy was relatively well tolerated except in three patients, including two mortalities. In our study, three-drug combination chemotherapy with Adriamycin, especially that including cis-platinum, was effective against transitional cell carcinoma of the urinary tract, but the results were not completely satisfactory.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Bristow MR, Mason JW, Billingham ME, Daniels JR (1978) Doxorubicin cardiomyopathy: Evaluation by phonocardiography, endomyocardial biopsy and cardiac catheterization. Ann Intern Med 88: 168
Carter SK (1978) Chemotherapy and genitourinary oncology. I. Bladder cancer. Cancer Treat Rev 5: 85
Carter SK, Wasserman TH (1975) The chemotherapy of urologic cancer. Cancer 36: 729
Cortes EP, Gupta M, Chou C, Amin VC, Folkers K (1978) Adriamycin cardiotoxicity: Early detection by systolic time interval and possible prevention by coenzyme Q10. Cancer Treat Rep 62: 887
Cross RJ, Glashan RW, Humphrey CS, Robinson MRG, Smith PH, Williams RE (1976) Treatment of advanced bladder cancer with adriamycin and 5-fluorouracil Br J Urol 48: 609
Dana BW, Jones SE (1982) Doxorubicin cardiotoxicity: Detection and prevention. In: Jones SE (ed) Current concepts in the use of doxorubicin chemotherapy. Farmitalia/Carlo Erba, Milano, p 157
deKernion JB (1977) The chemotherapy of advanced bladder cancer. Cancer Res 37: 2771
EORTC Urological Group B (1977) The treatment of advanced carcinoma of the bladder with a combination of Adriamycin and 5-fluorouracil. Eur Urol 3: 276
Fosså SD, Gudmundsen TE (1981) Single-drug chemotherapy with 5-FU and adriamycin in metastatic bladder carcinoma. Br J Urol 53: 320
Kedia KR, Gibbons C, Persky L (1981) The management of advanced bladder carcinoma. J Urol 125: 655
Lefrak EA, Pitha J, Rosenheim S, Gottlieb JA (1973) A clinicopathologic analysis of adriamycin cardiotoxicity. Cancer 32: 302
Merrin C, Cartagena R, Wajsman Z, Baumgartner G, Murphy GP (1975) Chemotherapy of bladder carcinoma with cyclophosphamide and adriamycin. J Urol 114: 884
O'Bryan RM, Luce JK, Talley RW, Gottlieb JA, Baker LH, Bonadonna G (1973) Phase II evaluation of adriamycin in human neoplasia. Cancer 32: 1
Samueles ML (1979) CISCA combination chemotherapy. In: Second Annual Conference on Cancer of Genitourinary Tract. Raven Press, New York, p 97
Smalley RV, Bartolucci AA, Hemstreet G, Hester M (1981) A phase II evaluation of a 3-drug combination cyclophsphamide, doxorubicin and 5-fluorouracil and of 5-fluorouracil in patients with advanced bladder carcinoma or stage D prostatic carcinoma. J Urol 125: 191
Smith PH (1981) Chemotherapy of bladder carcinoma: A review. Cancer Treat Rep 65: 165
Soloway MS (1978) cis-Diamminedichloroplatinum II in advanced urothelial cancer. J Urol 120: 716
Sternberg JJ, Bracken RB, Handel PB, Johnson DE (1977) Combination chemotherapy (CISCA) for advanced urinary tract carcinoma: A preliminary report. JAMA 238: 2282
Torner MD (1979) Cyclophosphamide, adriamycin and platinum (CAP) in the treatment of urothelial malignancy. Proc Am Assoc Cancer Res 20: 117
UICC (1978) Bladder. In: TNM classification of malignant tumors, 3rd edn. UICC, Geneva, p 113
Veronesi A, Magri MD, Digoli F, Tirelli U, Galligioni E, Trovo MG, Mserlo A, DalBO V, Tumolo S, Grigoletto E (1982) Combination chemotherapy with adriamycin and 5-fluorouracil in advanced bladder carcinoma. Clin Oncol 8: 103
Williams SD, Einhorn LH, Donohue JP (1981) cis-Platinum combination treatment for bladder cancer. In: Oliver RTD, Henry WF, Bloom HJG (eds) Bladder cancer — Principles of combination therapy. Butterworths, London, p 207
Yagoda A (1980a) Chemotherapy of metastatic bladder cancer. Cancer 45: 1879
Yagoda A (1980b) Cisplatin regimens in the treatment of bladder and penile cancer. In: Cisplatin current status and new developments. Academic Press, New York, p 361
Yagoda A (1982) Progress in the chemotherapeutic treatment of advanced bladder cancer. In: Clinical bladder cancer. Plenum Press, New York, p 113
Yagoda A, Watson RC, Gonzale-Vitale JC, Grabstald H, Whitmore WF (1976) cis-Dichlorodiammineplatinum (II) in advanded bladder cancer. Cancer Treat Rep 60: 917
Yagoda A, Watson RC, Grabstald H, Barzell WF, Whitmore WF (1977) Adriamycin and cyclophosphamide in advanced bladder cancer. Cancer Treat Rep 61: 97
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Kotake, T., Usami, M., Miki, T. et al. Combination chemotherapy including Adriamycin for advanced transitional cell carcinoma of the urinary tract. Cancer Chemother. Pharmacol. 11 (Suppl 1), S38–S42 (1983). https://doi.org/10.1007/BF00256716
Issue Date:
DOI: https://doi.org/10.1007/BF00256716